Investigation on structurally different Cu(II) and Ni(II) complexes constructed from a novel pyridine-terminal salamo-like ligand
Sign Up to like & getrecommendations! Published in 2020 at "Inorganica Chimica Acta"
DOI: 10.1016/j.ica.2020.120095
Abstract: Abstract A novel structurally characterized salamo-like ligand H2L contained double terminal pyridine groups was designed and synthesized. The single crystals of the Cu(II) and Ni(II) complexes are grown up through coordination of H2L with Cu(II)… read more here.
Keywords: ligand moiety; like ligand; geometry; ligand ... See more keywords
Complexes of cis-dioxomolybdenum(VI) with a chiral tetradentate tripodal-like ligand system: Syntheses, structures and catalytic activities
Sign Up to like & getrecommendations! Published in 2017 at "Polyhedron"
DOI: 10.1016/j.poly.2016.08.025
Abstract: Abstract Racemic complexes with the general formula cis -[MoO 2 (bzacL n )] ( 1 – 4 ) (H 2 bzacL n = 2-((4/5-R-2-hydroxyphenylamino)(pyridin-2-yl)methyl)-1-phenylbutane-1,3-dione, where n = 1–4 for R = H, 5-Me, 5-Cl and 4-Me, respectively and 2Hs… read more here.
Keywords: bzacl; like ligand; tripodal like; ligand system ... See more keywords
Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2203820119
Abstract: Significance Neuroendocrine prostate cancer (NEPC) is a highly aggressive variant of prostate cancer with few meaningful treatment options. As a result, patients have a poor prognosis once diagnosis is confirmed. NEPC expresses a unique protein… read more here.
Keywords: prostate cancer; prostate; neuroendocrine prostate; like ligand ... See more keywords
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2071703
Abstract: ABSTRACT Introduction Neuroendocrine carcinomas are very aggressive tumors with few treatment options. DLL3 seems to be an optimal target for therapeutic intervention, as it is expressed mainly on the membrane of tumor cells with neuroendocrine… read more here.
Keywords: neuroendocrine origin; ligand dll3; target; like ligand ... See more keywords